Searched for
CANCEL DRUGS IN INDIA
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
WHO seeks details from India over oxytocin-linked deaths; licences of manufacturer cancelledThe World Health Organisation (WHO) has sought details from the Indian government after reports linked oxytocin injections made by Jackson ...
India raises price cap on cancer drugs to tackle shortageIndia's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...
India’s rising export champion faces a critical credibility testIndia's seafood exports are soaring, reaching record highs and aiming for $30 billion within five years. Despite overcoming US tariffs and ...
Twisha Sharma death case: Cops yet to reach out to me for recording my statement, says mom-in-lawFormer judge Giribala Singh is booked in a dowry death case. She states police have not contacted her for a statement. Singh cites a chaoti...
Who is Ashok Bahar? The 71-year-old who appeared for NEET to fulfil a promise to his mother, only for 2026 paper leak to change everythingNEET UG 2026 paper leak: Ashok Bahar, a 71-year-old from Uttar Pradesh, pursued his lifelong dream of becoming a doctor by appearing for th...
Stocks in news: RIL, IDFC First Bank, Paytm, Sun Pharma, Manappuram FinanceIndian markets faced pressure extending a corrective phase. Key companies like RIL, IDFC First Bank, and Paytm reported their financial res...
Govt cracks down on GLP-1 drugs: Safety first amid weight-loss hypeIndia's government has released strict rules for GLP-1 drugs, used for diabetes and obesity. These powerful medications are now prescriptio...
Centre steps up oversight on GLP-1 drugs amid concerns over 'improper' practicesIndia's drug regulator is increasing oversight of GLP-1 weight loss drugs. Inspections across 49 entities revealed violations like unauthor...
Indian govt to take action against 76 drug companies for shoddy productsHealth Minister Mansukh Mandaviya confirmed a crackdown but did not give details of companies against which action had been taken.
Licences of 18 pharma companies cancelled for manufacturing spurious drugs"Licences of 18 pharma companies have been cancelled for manufacturing spurious and adulterated drugs and for violating GMP (good manufactu...
Uzbek cough syrup deaths: Process underway to cancel license of Marion Biotech, says officialAll production of drugs and other activities at the firm's campus in Sector 67 here have also been stopped completely, Gautam Buddh Nagar d...
- Maha govt upholds FDA move to cancel licence of J&J facility
Maharashtra today upheld the FDA Commissioner's decision to cancel Johnson & Johnson India's licence to manufacture healthcare products fro...
- Pharmaceutical companies told to submit safety reports on new drugs every 6 months
Companies which failed to report their safety status should do so within 3 weeks to retain their drug licences, the DGCI said.
- Submit mandatory safety report of new drugs or face license cancellation: DCGI to Drug companies
The country's drug regulator has asked drug companies to submit the mandatory safety reports of their new drugs for every six months for th...
- CCI cracks down on pharma companies for unfair trade practises
The competition commission of India has cracked a whip on the Indian drug manufacturers for encouraging unfair trade practises by colluding...
- Chinese drug firm turns back inspectors, may lose licence
India will terminate the licence of a Chinese drug manufacturing firm for not allowing an Indian delegation to inspect its premises and man...
- India to tighten scrutiny on bulk drug imports from China
Indian authorities will tighten their vigil on bulk drug imports from China after cancelling registrations from ten Chinese companies last ...
- Drug regulator bans raw material import from 10 Chinese firms
The country’s drug regulator has banned import of raw material from 10 Chinese drug companies for supplying products without having the man...
- GMPs may take toll on drug exports
In what could hit the country’s vaccine exports estimated to be at Rs 1,500 crore, besides maligning the reputation of Indian companies, WH...